A recent in silico analysis suggested the RNA genome of SARS-CoV-2 is a suitable substrate for DICER activity and enoxacin is a promising candidate for COVID-19 treatment (Ahmadi and Moradi, 2021). This evidence concerns the gene DICER1 and COVID-19.